Abeona Therapeutics Inc.
Exchange: IEX Type: Common StockRemote Buying of Abeona Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is readyRemote Selling of Abeona Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Medicenna Therapeutics (MDNAF) Presents supplementary data for MDNA55 and MDNA11 at ASCO 2020 - Slideshow via Seeking Alpha
Hedge Funds Have Never Been Less Bullish On Seres Therapeutics Inc (MCRB) via Yahoo Finance
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.
Analysis is available when the exchange & market are open.